Uncategorized
Aura Biosciences Expands Executive Leadership Team and Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the appointment of Chris Primiano, J.D., as Chief Business Officer and the appointment of Antony Mattessich to its Board of Directors. “We are delighted to welcome Chris to our team and Antony to the Board during an important transformational period for Aura. Both of their experiences in st